Related Experiment Videos
[Heart transplantation: indications and results]
C Scharf1, H P Brunner, E Oechslin
1Abteilung für Kardiologie, Universitätsspital Zürich.
Therapeutische Umschau. Revue Therapeutique
|June 22, 2000
Summary
Heart transplantation is a viable therapy for end-stage heart failure patients. Advances in treatment may postpone or avoid transplantation, necessitating close monitoring for optimal timing.
Area of Science:
- Cardiology
- Transplantation Medicine
Context:
- Heart transplantation is a critical treatment for end-stage heart failure (NYHA III-IV) unresponsive to conventional therapies.
- Objective criteria like peak oxygen consumption and pulmonary resistance guide transplant suitability.
- Improvements in heart failure management may allow for postponement or avoidance of transplantation.
Purpose:
- To outline the current status and criteria for heart transplantation.
- To discuss the impact of advanced heart failure therapies on transplantation decisions.
- To highlight the importance of specialized clinics and collaboration for patient management.
Summary:
- Heart transplantation is established for severe heart failure, with criteria including oxygen consumption and pulmonary resistance.
- Optimized medical and surgical care can delay or obviate the need for transplantation.
- Long-term survival is 63% at 10 years, but graft coronary artery disease and lymphomas remain challenges.
Impact:
- Enhanced medical management can help select the optimal time for heart transplantation, potentially improving outcomes.
- Close monitoring in specialized heart failure/transplant clinics is crucial for managing severely ill patients.
- Successful outcomes depend on vigilant clinical monitoring, risk factor management, and strong patient-physician cooperation.